Skip to content

Logs: Bang Zheng

The following is a list of all job requests run via OpenSAFELY by Bang Zheng.
Status Organisation Project Workspace Request ID Backend Jobs Started View request
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 21527 TPP 2/2 2 years ago 10 December 2023 21:10:39 UTC View, Job request 21527
Succeeded The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid 21525 TPP 1/1 2 years ago 09 December 2023 16:57:51 UTC View, Job request 21525
Succeeded The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid 21524 TPP 1/1 2 years ago 09 December 2023 13:21:24 UTC View, Job request 21524
Succeeded The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid 21508 TPP 1/1 2 years ago 06 December 2023 18:17:56 UTC View, Job request 21508
Succeeded The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid 21507 TPP 2/2 2 years ago 06 December 2023 18:00:05 UTC View, Job request 21507
Failed The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid 21506 TPP 0/1 2 years ago 06 December 2023 17:34:35 UTC View, Job request 21506
Failed The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid 21499 TPP 0/1 2 years ago 06 December 2023 13:06:02 UTC View, Job request 21499
Succeeded The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid 21431 TPP 1/1 2 years ago 29 November 2023 23:21:59 UTC View, Job request 21431
Succeeded The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid 21420 TPP 1/1 2 years ago 29 November 2023 15:55:52 UTC View, Job request 21420
Failed The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid 21381 TPP 0/1 2 years ago 29 November 2023 00:22:51 UTC View, Job request 21381
Succeeded The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid 21365 TPP 1/1 2 years ago 28 November 2023 13:06:05 UTC View, Job request 21365
Failed The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid 21358 TPP 0/1 2 years ago 28 November 2023 09:24:34 UTC View, Job request 21358
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 21087 TPP 2/2 2 years, 1 month ago 13 November 2023 11:51:08 UTC View, Job request 21087
Succeeded The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid 20807 TPP 7/7 2 years, 1 month ago 22 October 2023 08:15:06 UTC View, Job request 20807
Succeeded The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid 20793 TPP 1/1 2 years, 1 month ago 19 October 2023 20:52:54 UTC View, Job request 20793
Failed The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid 20784 TPP 0/1 2 years, 1 month ago 19 October 2023 12:19:14 UTC View, Job request 20784
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 20635 TPP 1/1 2 years, 2 months ago 05 October 2023 20:43:58 UTC View, Job request 20635
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 20614 TPP 1/1 2 years, 2 months ago 04 October 2023 22:47:49 UTC View, Job request 20614
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 20461 TPP 1/1 2 years, 2 months ago 21 September 2023 09:24:05 UTC View, Job request 20461
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 20453 TPP 1/1 2 years, 2 months ago 20 September 2023 17:15:46 UTC View, Job request 20453
Failed Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 20452 TPP 0/1 2 years, 2 months ago 20 September 2023 15:47:02 UTC View, Job request 20452
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 20396 TPP 1/1 2 years, 3 months ago 15 September 2023 13:05:22 UTC View, Job request 20396
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 20386 TPP 1/1 2 years, 3 months ago 14 September 2023 23:37:23 UTC View, Job request 20386
Failed Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 20372 TPP 0/1 2 years, 3 months ago 14 September 2023 10:58:23 UTC View, Job request 20372
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 paxlovid_sotrovimab 20332 TPP 1/1 2 years, 3 months ago 12 September 2023 20:10:55 UTC View, Job request 20332